Fujii Kengo, Yamazaki Masashi, Kang James D, Risbud Makarand V, Cho Samuel K, Qureshi Sheeraz A, Hecht Andrew C, Iatridis James C
Leni & Peter W. May Department of Orthopaedics Icahn School of Medicine at Mount Sinai New York NY USA.
Department of Orthopaedic Surgery University of Tsukuba Tsukuba Japan.
JBMR Plus. 2019 Mar 4;3(5):e10180. doi: 10.1002/jbm4.10180. eCollection 2019 May.
Discogenic back pain is multifactorial; hence, physicians often struggle to identify the underlying source of the pain. As a result, discogenic back pain is often hard to treat-even more so when clinical treatment strategies are of questionable efficacy. Based on a broad literature review, our aim was to define discogenic back pain into a series of more specific and interacting pathologies, and to highlight the need to develop novel approaches and treatment strategies for this challenging and unmet clinical need. Discogenic pain involves degenerative changes of the intervertebral disc, including structural defects that result in biomechanical instability and inflammation. These degenerative changes in intervertebral discs closely intersect with the peripheral and central nervous systems to cause nerve sensitization and ingrowth; eventually central sensitization results in a chronic pain condition. Existing imaging modalities are nonspecific to pain symptoms, whereas discography methods that are more specific have known comorbidities based on intervertebral disc puncture and injection. As a result, alternative noninvasive and specific diagnostic methods are needed to better diagnose and identify specific conditions and sources of pain that can be more directly treated. Currently, there are many treatments/interventions for discogenic back pain. Nevertheless, many surgical approaches for discogenic pain have limited efficacy, thus accentuating the need for the development of novel treatments. Regenerative therapies, such as biologics, cell-based therapy, intervertebral disc repair, and gene-based therapy, offer the most promise and have many advantages over current therapies. © 2019 The Authors. Published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.
椎间盘源性背痛是多因素导致的;因此,医生常常难以确定疼痛的根本来源。结果,椎间盘源性背痛往往难以治疗——当临床治疗策略的疗效存疑时更是如此。基于广泛的文献综述,我们的目标是将椎间盘源性背痛定义为一系列更具体且相互作用的病理状况,并强调针对这一具有挑战性且未得到满足的临床需求开发新方法和治疗策略的必要性。椎间盘源性疼痛涉及椎间盘的退行性改变,包括导致生物力学不稳定和炎症的结构缺陷。椎间盘的这些退行性改变与外周和中枢神经系统密切相关,从而导致神经致敏和神经长入;最终,中枢致敏导致慢性疼痛状态。现有的成像方式对疼痛症状不具有特异性,而更具特异性的椎间盘造影方法则因椎间盘穿刺和注射存在已知的合并症。因此,需要替代性的非侵入性且特异性的诊断方法,以更好地诊断和识别可更直接治疗的特定病情和疼痛来源。目前,针对椎间盘源性背痛有许多治疗方法/干预措施。然而,许多针对椎间盘源性疼痛的手术方法疗效有限,因此更凸显了开发新治疗方法的必要性。再生疗法,如生物制剂、基于细胞的疗法、椎间盘修复和基于基因的疗法,最具前景,且与现有疗法相比有许多优势。© 2019作者。由Wiley Periodicals, Inc.代表美国骨与矿物质研究学会出版。